Alzheimer's Disease
Showing NaN - NaN of 79
Alzheimer's Disease, Dementia Trial in Toronto (Cholinesterase Inhibitor, Placebo)
Completed
- Alzheimer's Disease
- Dementia
- Cholinesterase Inhibitor
- Placebo
-
Toronto, Ontario, Canada
- +1 more
Apr 26, 2017
Alzheimer's Disease, Dementia Trial in Worldwide (Drug: EVP-6124, Placebo)
Terminated
- Alzheimer's Disease
- Dementia
- Drug: EVP-6124
- Placebo
-
Phoenix, Arizona
- +81 more
May 2, 2016
Alzheimer's Disease Neuroimaging Initiative Grand Opportunity
Completed
- Mild Cognitive Impairment
- Alzheimer's Disease
-
Birmingham, Alabama
- +54 more
Sep 15, 2014
Alzheimer's Disease Trial in Worldwide (BMS-241027, Placebo matching BMS-241027)
Completed
- Alzheimer's Disease
- BMS-241027
- Placebo matching BMS-241027
-
Anaheim, California
- +23 more
Jul 23, 2014
Alzheimer's Disease, Agitation Trial in Canada, United States (citalopram, )
Completed
- Alzheimer's Disease
- Agitation
- citalopram
- placebo
-
Los Angeles, California
- +7 more
Jun 26, 2014
Alzheimer's Disease Trial in Canada (Memantine, Placebo)
Alzheimer's Disease Trial in Worldwide (Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg)
Completed
- Alzheimer's Disease
- Bapineuzumab 0.5 mg/kg
- +2 more
-
Birmingham, Alabama
- +250 more
Oct 30, 2013
Alzheimer's Disease Trial in Canada (Memantine)
Terminated
- Alzheimer's Disease
-
Edmonton, Alberta, Canada
- +32 more
Jul 26, 2012
Alzheimer's Disease Trial in Worldwide (Lu AE58054, Placebo)
Completed
- Alzheimer's Disease
- Lu AE58054
- Placebo
-
East Gosford, Australia
- +50 more
Jan 5, 2012
Alzheimer's Disease, Dementia Trial in Worldwide (Donepezil HCl)
Completed
- Alzheimer's Disease
- Dementia
- Donepezil hydrochloride
-
Northport, Alabama
- +41 more
Mar 31, 2011